conserved epigenomic signals mice humans reveal immune basis alzheimers disease 
alzheimers disease ad severe1 age-related neurodegenerative disorder characterized accumulation amyloid-beta plaques neurofibrillary tangles synaptic neuronal loss cognitive decline several genes implicated ad chromatin state alterations neurodegeneration remain uncharacterized profile transcriptional chromatin state dynamics across early late pathology hippocampus inducible mouse model ad-like neurodegeneration find coordinated down-regulation synaptic plasticity genes regulatory regions upregulation immune response genes regulatory regions targeted factors belong ets family transcriptional regulators including pu1 human regions orthologous increasing-level enhancers show immune-cell-specific enhancer signatures well immune cell expression quantitative trait loci decreasing-level enhancer orthologues show fetal-brain-specific enhancer activity notably ad-associated genetic variants specifically enriched increasing-level enhancer orthologues implicating immune processes ad predisposition indeed increasing enhancers overlap known ad loci lacking protein-altering variants implicate additional loci reach genome-wide significance results reveal new insights mechanisms neurodegeneration establish mouse useful model functional studies ad regulatory regions 
